From the *The Pediatric Infectious Disease Unit, Soroka University Medical Center and the Faculty of Health Sciences, Ben-Gurion University of the Negev, Beer-Sheva, Israel; †Division of Maternal and Child Health, Aga Khan University, Karachi, Pakistan; ‡Sabin Vaccine Institute, Washington, DC; §European Society of Clinical Microbiology and Infectious Diseases, Barcelona, Spain; ¶William H. Foege Chair in Global Health, Rollins School of Public Health, Emory University, Atlanta, GA; ∥Division of Infectious Disease, Jordan University Hospital, Amman, Jordan; **International Vaccine Access Center, Johns Hopkins University, Baltimore, MD; ††Department of Microbiology, Bangladesh Institute of Child Health, Dhaka Shishu Hospital, Dhaka, Bangladesh; ‡‡Center for Vaccine Development, Bamako, Mali; §§Kenya Paediatric Association, Nairobi, Kenya; and ¶¶Pediatrics, Beijing Children's Hospital, Beijing, China.
Accepted for publication September 7, 2010.
Supported by Sabin Vaccine Institute, Pneumococcal Awareness Council of Experts.
Address for correspondence: Ron Dagan, MD, Pediatric Infectious Disease Unit, Soroka University Medical Center, POB 15, Beer-Sheva 84101 Israel. E-mail: firstname.lastname@example.org.